Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Ease ... Question

Ease ... Question

posted on Oct 16, 2006 08:02AM
Do you think it is possible that as a result of the Intellasys/Sony deal, TPL waived receipt of their typical cut of licensing revenue from Sony? If so, that suggests that PTSC could receive essentially 100% of the total license fee from Sony. Pohl's comments in the 10K state the total aggregate received for the first four months, but not the cut. I know it may be wishful thinking, but this option would provide a sweet deal for Sony without penalizing PTSC. Best regards.
Share
New Message
Please login to post a reply